Abstract
Breast cancer screening is defined as the evaluation of a population of asymptomatic women (healthy pre- and postmenopausal women), who have no overt signs or symptoms of breast cancer, aimed to detect unsuspected cancer earlier in its growth, which would not be diagnosed without the application of a screening test. There are a wide variety of screening programs practiced across the world: the most popularly used are the screening mammograms. Though there are some significant merits of screening mammograms like early diagnosis and early treatment, which in turn reduces the mortality and morbidity rate, many claim that there are a few disadvantages to screening programs with mammography, like false positivity, high cost, and risk of ionizing radiation. In this chapter, we aim to give a brief review of the advantage, discuss if these disadvantages are justifiable, and, most importantly, the various recent screening recommendations proposed and followed across the world.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Cancer Tomorrow. International agency for research on cancer. http://gco.iarc.fr/tomorrow/graphicisotype?type=0&population=900&mode=population&sex=2&cancer=39&age_group=value& apc male=0&apc_female=0. Accessed 5 Jan 2020.
Tabár L, Fagerberg CJG, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography: randomized trial from the breast cancer screening working group of the Swedish national board of health and welfare. Lancet. 1985;1:829–32.
Tabar L, Fagerberg G, Chen HH, et al. Efficacy of breast cancer screening by age. New results from the Swedish two-county trial. Cancer. 1995;75:2507–17.
Fletcher SW, Elmore JG. Clinical practice: mammographic screening for breast cancer. N Engl J Med. 2003;348:1672–80.
Barth RJ Jr, Gibson GR, Carney PA, Mott LA, Becher RD, Poplack SP. Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy. AJR Am J Roentgenol. 2005;184:324–9.
US Preventive Services Task Force. Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2009;1519(10):716–26. W-236.
Lee CH, Dershaw DD, Kopans D, Evans P, Monsees B, Monticciolo D, et al. Breast cancer screening with imaging: recommendations from the society of breast imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol. 2010;7:18–27.
Forrest P. Department of Health and Social Security. Breast cancer screening, report to the Health Ministers of England, Wales, Scotland, and Northern Ireland. London, UK: Her Majesty’s Stationery Office; 1986.
Patnick J. NHS Cancer Screening Programmes. NHS Breast Screening Programme Annual Review 2010, Overcoming Barriers. Sheffield, UK; 2010.
Giordano L, von Karsa L, Tomatis M, Majek O, de Wolf C, Lancucki L, Eunice Working Group, et al. Mammographic screening programmes in Europe: organization, coverage and participation. J Med Screen. 2012;19(Suppl 1):72–82.
Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty-five-year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomized screening trial. BMJ. 2014;348:366.
Australian Government, Australian Institute of Health, and Welfare (AIHW). Breast Screen Australia monitoring report 2010–2011. Cancer Series No. 77. Canberra: AIHW; 2013.
Zakharova N, Duffy SW, Mackay J, Kotlyarov E. The introduction of a breast cancer screening programme in a region with a population at medium risk for developing breast cancer: Khanty-Mansiysky autonomous OkrugUgra (Russian Federation). Ecancermedicalscience. 2011;5:195.
Apffelstaedt J. Reflections on the USPSTF breast screening recommendations from a South African perspective. S Afr J Gynaecol Oncol. 2010;2:13–4.
Wang F, Zhi-Gang Y. Current status of breast cancer prevention in China Department of Breast Surgery. Chron Dis Transl Med. 2015;1:2–8.
Porter PL. Global trends in breast cancer incidence and mortality. Salud Publica Mex. 2009;51(Suppl 2):S141–6.
Ferlay J, Bray F, Pisani P, GLOBOCAN, et al. Cancer incidence, mortality and prevalence worldwide. In: IARC cancer-base No 5, Version 2.0. Lyon: IARC; 2002. http://www-dep.iarc.fr/globocan/database.htm.
FDA. Mammography quality standards act of 1992. Mammography facilities requirement for accrediting bodies, and quality standards and certifying requirements: interim rules (21 CFR 900). 1993;58:57558–57572.
Kopans DB. An open letter to panels that are deciding guidelines for breast cancer screening. Breast Cancer Res Treat. 2015;151(1):19–25. https://doi.org/10.1007/s10549-015-3373-8.
Spivey GH, Perry BW, Clark VA. Predicting the risk of cancer at the time of breast biopsy. Am Surg. 1982;48(7):326–32.
Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367(21):1998–2005.
Kopans DB. Screening for breast cancer and mortality reduction among women 40–49 years of age. Cancer. 1994;74(1 Suppl):311–22.
Pauwels EKJ, Foray N, Bourguignon MH. Breast cancer induced by X-ray mammography screening? A review based on recent understanding of low-dose radiobiology. Med Princ Pract. 2016;25(2):101–9. https://doi.org/10.1159/000442442.
Kösters JP, Gøtzsche PC. Regular self-examination or clinical examination for early detection of breast cancer. Cochrane Database Syst Rev. 2008;2003(3):CD003373.
Berg WA, Bandos AI, Mendelson EB, Lehrer D, Jong RA, Pisano ED. Ultrasound as the primary screening test for breast cancer: analysis from ACRIN 6666. J Natl Cancer Inst. 2015;108(4):djv367.
Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, et al. Supplemental screening for breast cancer in women with dense breasts: a systematic review for the U.S. Preventive Service Task Force. 2016;164(4):268–78.
American College of Obstetricians and Gynaecologists. Response of the American College of Obstetricians and Gynaecologists to new breast cancer screening recommendations from the U.S. Preventive Services Task Force; 2010.
Ren W, Chen M, Qiao Y, Zhao F. Global guidelines for breast cancer screening: a systematic review. Breast. 2022;64:85–99. https://doi.org/10.1016/j.breast.2022.04.003.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Palanisamy, P.K., Dev, B., Gnanavel, H. (2023). Screening Recommendations. In: Dev, B., Joseph, L.D. (eds) Holistic Approach to Breast Disease. Springer, Singapore. https://doi.org/10.1007/978-981-99-0035-0_7
Download citation
DOI: https://doi.org/10.1007/978-981-99-0035-0_7
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-0034-3
Online ISBN: 978-981-99-0035-0
eBook Packages: MedicineMedicine (R0)